Circulating Tumor DNA in Soft Tissue Sarcoma
common.study.values.description
“Circulating Tumor DNA in Soft Tissue Sarcoma”
This research study will collect blood and tumor tissue samples from patients with soft tissue sarcoma to look at circulating tumor deoxyribonucleic acid (DNA). When tumor cells are damaged or die, DNA from the tumor cells are released into the blood stream as the cells break down. This is called circulating tumor DNA. Circulating tumor DNA is an important biomarker that may be used in cancer detection, prediction of treatment response, and disease monitoring.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-no
common.study.methods.is-healthy-yes
Procedure - Archival tumor tissue collection and blood draws
Archival tumor tissue will be collected for testing of circulating tumor DNA. Blood draws will be taken for testing of circulating tumor DNA.
participant.views.study.view.additional
participant.views.study.view.scientific-title
Circulating Tumor DNA Detection in Soft Tissue Sarcoma (DNA-TSAR)
common.study.values.clinical-trial-id
NCT03818412
participant.views.study.view.id
azpY7d
